By utilizing cutting edge technology, established scientific methods, an entrepreneurial work ethic, and strategic alliances, MedImmune's scientists have built a diverse research and development pipeline.
More information on candidate drugs in Phase 1, Phase 2, and Phase 3 is available.
Information about MedImmune's R&D pipeline is updated on a quarterly basis, based on publicly available information.
Although we make a good faith effort to keep this content as current as possible, we do not have a duty to update information posted on our web site, and we will not be liable for any failure to update such information.